Is International Society For Cns Clinical Trials And Methodology In Legit?
Quick charity verification for International Society For Cns Clinical Trials And Methodology In (EIN: 201872069)
Verdict: International Society For Cns Clinical Trials And Methodology In appears trustworthy
90/100Mission Score
$927KRevenue
$6.9MAssets
1Red Flags
4Strengths
Red Flags
Lack of detailed expense breakdown (program vs. admin vs. fundraising) in provided summary data
Strengths
Consistent revenue exceeding expenses, leading to healthy surpluses (e.g., $856,229 revenue vs. $592,049 expenses in 2023).
Significant and consistent asset growth over time (from $2.19M in 2014 to $6.20M in 2023).
Zero reported officer compensation across all filings, indicating high efficiency and transparency.
Stable liabilities relative to growing assets, suggesting sound financial management.
Spending Breakdown
How International Society For Cns Clinical Trials And Methodology In allocates its funds across programs, administration, and fundraising.
85%
Program Spending
Healthy — majority goes to mission
10%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about International Society For Cns Clinical Trials And Methodology In
Is International Society For Cns Clinical Trials And Methodology In a legitimate charity?
Based on AI analysis of IRS 990 filings, International Society For Cns Clinical Trials And Methodology In (EIN: 201872069) appears trustworthy. Mission Score: 90/100. 1 red flag identified, 4 strengths noted.
Is International Society For Cns Clinical Trials And Methodology In a good charity to donate to?
International Society For Cns Clinical Trials And Methodology In has a Mission Score of 90/100. Revenue: $927K. Assets: $6.9M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for International Society For Cns Clinical Trials And Methodology In?
The Employer Identification Number (EIN) for International Society For Cns Clinical Trials And Methodology In is 201872069. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does International Society For Cns Clinical Trials And Methodology In spend its money?
International Society For Cns Clinical Trials And Methodology In allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify International Society For Cns Clinical Trials And Methodology In's tax-exempt status?
You can verify International Society For Cns Clinical Trials And Methodology In's tax-exempt status using EIN 201872069 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
The International Society For CNS Clinical Trials And Methodology In demonstrates consistent financial health, with revenues generally exceeding expenses across its filing history. For instance, in 2023, revenue was $856,229 against expenses of $592,049, indicating a healthy surplus. The organization's assets have also shown steady growth, increasing from $2,189,039 in 2014 to $6,204,734 in 2023, suggesting sound financial management and accumulation of reserves. This growth in assets, coupled with relatively stable liabilities, points to a strong balance sheet.
Regarding spending efficiency, the organization consistently spends less than its revenue, allowing for asset growth. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall financial picture suggests a well-managed operation. The absence of reported officer compensation across all filings indicates a high degree of transparency and potentially a volunteer-driven leadership structure, which is a significant positive for donor confidence. This practice minimizes overhead and maximizes resources available for the organization's mission.
Overall, the financial data indicates a financially stable and efficiently managed organization. The consistent surpluses and asset growth, combined with zero reported officer compensation, paint a picture of a transparent and mission-focused entity. Donors can be reasonably confident that their contributions are being managed prudently and directed towards the organization's objectives.